AMBU B Ambu A/S Class B

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

In accordance with its long-term incentive program ("LTIP") Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29 January 2021 regarding the implementation of the program and the first allocations.

Pursuant to the Market Abuse Regulation article 19, Ambu A/S hereby notifies receipt of information of the following transactions in Ambu's shares by persons discharging managerial responsibilities in Ambu A/S. 

1.Details of the person discharging managerial responsibilities/person closely associated
a)NameMichael Højgaard Abrahamsen
2.Reason for the notification
a)Position/statusCFO
b)Initial notifica- tion/AmendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc-

tion monitor
a)NameAmbu A/S
b)LEI5299008W2A69WX355710
4.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instru- ment



 



Identification code
Performance Share Units linked to shares in Ambu A/S



 



 



 



 



DK0060946788
b)Nature of the transactionAllocation of Performance Share Units according to Long-Term Incentive Program.
c)Price(s) and volume(s) Price(s)Volume(s)
DKK 07,254 PSUs
  
  
  
  
d)Aggregated information
  • Aggregated volume
  • Price
 



N/A



 



N/A



 
e)Date of the transaction29 January 2021
f)Place of the transactionOutside a trading venue

Attachment



EN
29/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

Ambu AS: 1 director

A director at Ambu AS bought 2,800 shares at 15.412USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Jesper Ingildsen
  • Jesper Ingildsen

Ambu (Buy, TP: DKK144.00) - Possibly isolated softness

Q2 was below our forecast, but the softness might be isolated to Q2 on what could be Chinese competitors dumping stock ahead of tariffs, which could become a tailwind. Notably, the 2024/25 guidance was maintained and includes headwinds from FX and tariffs. We reiterate our BUY, but have cut our target price to DKK144 (155).

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch